PMC:7242013 / 1474-1750 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T12","span":{"begin":123,"end":128},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":"1 , 2 Moreover, prevention of severe COVID‐19 and related mortality requires updating management of persons with chronic liver disease (CLD) to diagnose COVID‐19 and being vigilant for drug‐drug interactions and other potential complications of COVID‐19 in persons with CLD."}

{"project":"LitCovid-PubTator","denotations":[{"id":"58","span":{"begin":102,"end":109},"obj":"Species"},{"id":"59","span":{"begin":259,"end":266},"obj":"Species"},{"id":"69","span":{"begin":39,"end":47},"obj":"Disease"},{"id":"70","span":{"begin":60,"end":69},"obj":"Disease"},{"id":"71","span":{"begin":115,"end":136},"obj":"Disease"},{"id":"72","span":{"begin":155,"end":163},"obj":"Disease"},{"id":"73","span":{"begin":247,"end":255},"obj":"Disease"}],"attributes":[{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"Tax:9606"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"Tax:9606"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"MESH:C000657245"},{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"MESH:D003643"},{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:D058625"},{"id":"A72","pred":"tao:has_database_id","subj":"72","obj":"MESH:C000657245"},{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"1 , 2 Moreover, prevention of severe COVID‐19 and related mortality requires updating management of persons with chronic liver disease (CLD) to diagnose COVID‐19 and being vigilant for drug‐drug interactions and other potential complications of COVID‐19 in persons with CLD."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T10","span":{"begin":123,"end":128},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"1 , 2 Moreover, prevention of severe COVID‐19 and related mortality requires updating management of persons with chronic liver disease (CLD) to diagnose COVID‐19 and being vigilant for drug‐drug interactions and other potential complications of COVID‐19 in persons with CLD."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T34","span":{"begin":39,"end":47},"obj":"Disease"},{"id":"T35","span":{"begin":123,"end":136},"obj":"Disease"},{"id":"T36","span":{"begin":138,"end":141},"obj":"Disease"},{"id":"T37","span":{"begin":155,"end":163},"obj":"Disease"},{"id":"T38","span":{"begin":247,"end":255},"obj":"Disease"},{"id":"T39","span":{"begin":272,"end":275},"obj":"Disease"}],"attributes":[{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005154"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0008964"},{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0008964"}],"text":"1 , 2 Moreover, prevention of severe COVID‐19 and related mortality requires updating management of persons with chronic liver disease (CLD) to diagnose COVID‐19 and being vigilant for drug‐drug interactions and other potential complications of COVID‐19 in persons with CLD."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T24","span":{"begin":123,"end":128},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T25","span":{"begin":123,"end":128},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":"1 , 2 Moreover, prevention of severe COVID‐19 and related mortality requires updating management of persons with chronic liver disease (CLD) to diagnose COVID‐19 and being vigilant for drug‐drug interactions and other potential complications of COVID‐19 in persons with CLD."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T11","span":{"begin":187,"end":191},"obj":"Chemical"},{"id":"T12","span":{"begin":192,"end":196},"obj":"Chemical"}],"attributes":[{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"1 , 2 Moreover, prevention of severe COVID‐19 and related mortality requires updating management of persons with chronic liver disease (CLD) to diagnose COVID‐19 and being vigilant for drug‐drug interactions and other potential complications of COVID‐19 in persons with CLD."}

{"project":"LitCovid-sentences","denotations":[{"id":"T28","span":{"begin":0,"end":276},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"1 , 2 Moreover, prevention of severe COVID‐19 and related mortality requires updating management of persons with chronic liver disease (CLD) to diagnose COVID‐19 and being vigilant for drug‐drug interactions and other potential complications of COVID‐19 in persons with CLD."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T10","span":{"begin":123,"end":136},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0001392"}],"text":"1 , 2 Moreover, prevention of severe COVID‐19 and related mortality requires updating management of persons with chronic liver disease (CLD) to diagnose COVID‐19 and being vigilant for drug‐drug interactions and other potential complications of COVID‐19 in persons with CLD."}